1018719-75-9Relevant articles and documents
Process development and scale-up of a pparγ agonist: Selection of the manufacture route
Bullock, Kae M.,Burton, Delphilia,Corona, John,Diederich, Ann,Glover, Bobby,Harvey, Kim,Mitchell, Mark B.,Trone, Mark D.,Yule, Robert,Zhang, Yong,Toczko, Jennifer F.
scheme or table, p. 303 - 309 (2010/04/22)
Two short, high-yielding routes to the selective PPARγ agonist GSK376501A were developed and carried out on scale. The key bond -forming reaction in each synthesis was the substitution of a 3,5-difluoro or 3,5-dibromo aryl intermediate with 2-methoxy-etha